Loading clinical trials...
Loading clinical trials...
An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Active-referenced (Paroxetine), Fixed-dose Study on the Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder
Conditions
Interventions
Vortioxetine 10 mg
Paroxetine 20 mg
+1 more
Locations
18
Estonia
EE001
Tallinn, Estonia
EE002
Tallinn, Estonia
EE004
Võru, Estonia
FI002
Helsinki, Finland
FI003
Helsinki, Finland
FI001
Kuopio, Finland
Start Date
October 1, 2014
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
February 28, 2017
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT05017311
Lead Sponsor
H. Lundbeck A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions